Invited Lectures

Invited Lecture at the National Meeting of the Medicinal Chemistry Divisio of the Italian Chemical Society, 17-20 September 2023, Chieti close to the Adriatic Sea, Italy.

Invited Speaker at the Sir Howard Dalton Centre Day, 22 Septemebr 2023, IBRB, School of Life Sciences, University of Warwick, UK. "Work performed at H3D and the challeges faced and demonstration of how an understanding of enzymology can help in traslational discovery".

Invited speaker at the 2023 Meeting of Tuberculosis Drug Discovery and Develeopment Seminar, Barcelone, Spain, 22-23 July 2023."Researchers to present their work, discuss new methods, cutting edge idear and pre-published data".

Invited Lecture at the the 23rd Tetrahedron Symposium in Gothenburg, Sweden, 27-30 June 2023. 

Invited Speaker at an ACS Publications Symposium." Biological/ Medicinal Chemistry Research". University of Bonn in Germany. 6-8 March 2023.

Invited Speaker at the Hybrid HIPS Talk as a speaker at the Helmholtz - Institute for Pharmaceutical Research in Saarland, Saarbrucken. "Mycobacterium Tuberculosis - Mediated Drug Metabolism Friend and Foe?". 2-4 March 2023.

Atlantic Basin Conference on Chemistry (ABCChem). Chemistry and Biology & Health plenary lecture, Marrakech, Morocco, 13-16 December 2022.

Invited Lecture in Brussels,Beerse at Johnson & Johnson 24 November 2022. Topic: 'Small molecule drug discovery to combat drug-resistant infections".

Invited Lecture in Brussels, Belgium at the European Commission. Pre-clinical research of broad-spectrum antivirals and present the work of H3D, 21-23 November 2022.

4th Annual meeting of the Crick African Network (CAN), Vineyard Hotel, Cape Town. Closing Keynote Lecture. Hosted by UCT and Stellenbosch University, 6-10 December 2022. Showcasing research and the translational approach taken in building H3D into a pathbreaking organization. Talks about Malaria, TB and AMR.

Global Health Drug Discovery in Africa: Challenges and Opportunities.. Invited Commemorative Fund Lecture at the American Society of Tropical Medicine and Hygiene (ASTMH), 2018 Annual Meeting at the Sheraton, New Orleans, October 30, 2018. This lecture—one of the Society’s most prestigious—is by invitation only from the President of ASTMH on behalf of the Council of ASTMH to a highly accomplished researcher from the tropics

Confronting Afro-pessimism. Invited Spotlight Talk at the 2018 Grand Challenges Meeting, Joint Plenary: Keystone Symposia: Innovation in Drug Discovery 18th October 2018, Berlin, Germany.

Innovation in health R&D – in Africa, for Africa. Invited Keynote Lecture at the Drug for Neglected Diseases initiative (DNDi) Partners meeting, Kampala, Uganda, 04 October 2018

PI4K inhibitors that target multiple life cycle stages of the human malaria parasite.  Invited Lecture at the 19th Royal Society of Chemistry (RSC / Society of Chemical Industries (SCI) Medicinal Chemistry Symposium, 10th-13th September 2017, Churchill College, University of Cambridge, UK

Accelerating sustainable pharmaceutical Research and Development in Africa. Invited Keynote Lecture at Planet Earth Institute (PEI) #ScienceAfrica UnConference “Big Ideas for Africa: Celebrating the Continent’s Science and Technology Pioneers”. London, UK, 20 July 2017

Next generation PI4K inhibitors that impact the entire parasite life cycle. Invited lecture at the XIX International Congress for Tropical Medicine and Malaria (ICTMM), 18-22 September 2016, Brisbane, Australia.

Recent Drug Discovery case histories for malaria. Invited lecture at the Canada Malaria Symposium, Science and policy shield the vulnerable from malaria, 20 June, 2016, McGill University, Montreal, Canada.

Antimalarials from SoftFocus Libraries: Optimization and Target Identification. Invited lecture at the Keystone Symposium, Drug Discovery for Parasitic Diseases, 24-29 January, 2016, Granlibakken Resort, Tahoe City, California, USA.

African-Led Health Innovation to Tackle Global Health Challenges through Partnerships: The H3D Example. Invited Lecture at the 9th European Congress on Tropical Medicine and International Health (ECTMIH) as part of GHIT Symposium “The Japanese contribution to tackle global”, 6-10 September 2015, Basel, Switzerland

The 1st Small Molecule Clinical Candidate Discovered in Africa. Invited Lecture at the American Chemical Society (ACS) symposium entitled "New Models for Drug Discovery', 249th ACS National Meeting in Denver, Colorado, March 22nd – 25th, 2015, USA.

Medicinal chemistry progression of phenotypic HTS hits for TB from SoftFocus libraries. Invited lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 21-26 July 2013, Lucca, Barga, Italy. Under session “Compounds”.  .

Hit to Lead and Lead Optimization of Antimalarial and Antituberculosis Whole Cell Hits from a SoftFocus Library. Invited Lecture at the American Chemical Society (ACS)  symposium entitled "Challenges in Phenotypic Whole Cell High throughput Screening and Medicinal Chemistry Optimization of Hits; Strategies to Discover Novel Antiparasitic and Antimycobacterial Agents", 243rd ACS National Meeting 25-29 March 2012, San Diego, California, USA. 

Chemical Approaches to the Reversal of Chloroquine Resistance in the Malaria Parasite Plasmodium falciparum. Invited Keynote Lecture at the 7th Asian International Medicinal Chemistry (AIMECS09) Congress, Cairns, Australia, 23-27 August 2009.

Privileged Structures and Multi-Component Reaction Strategies in Antiprotozoal Drug Discovery.  Invited lecture at the Keystone Symposia, Drugs Against Protozoan Parasites, 28 Jan-1 February 2007, Lake Tahoe, Tahoe City, California, USA.

Pharmacophore for the Rational Design of Chemosensitizers Against Drug Resistant Malaria Parasites.  Invited lecture at the American Chemical Society-Council for Scientific and Industrial Research (India) conference on Advances in Organic Chemistry and Chemical Biology (AOCCB), 11-12 Jan 2006, Indian Institute of Chemical Technology (IICT), Hyderabad, India.

Acetolactate Synthase Inhibitors as Novel Anti-tuberculosis Agents. Plenary lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 31 Aug -5 Sept 2003, Queens’ College, University of Oxford, UK.